Photobiomodulation on Core Symptoms of Autism

Brief summary (registry, in English)

This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.

What you commit to

• Study type: Interventional
• Planned participants: 30
• From 10 Apr 2026 to the primary completion date, 10 Jul 2026
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 2 years to 6 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov